Prostate Cancer Stocks List

Related Stock Lists: Cancer Medicine Cancers Biotechnology Chemistry Clinical Medicine Health Oncology Biopharmaceutical Pain Breast Cancer Chemotherapy Medical Specialties Solid Tumors Treatment Of Cancer Immunotherapies Immunotherapy Infectious Diseases Influenza Ovarian Cancer

Recent Signals

Date Stock Signal Type
2020-05-27 ABBV Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 ACHV Fell Below 20 DMA Bearish
2020-05-27 ADMP Fell Below 20 DMA Bearish
2020-05-27 ADXS Crossed Above 20 DMA Bullish
2020-05-27 ADXS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 ADXS Bollinger Band Squeeze Range Contraction
2020-05-27 ADXS Hammer Candlestick Bullish
2020-05-27 AEZS Calm After Storm Range Contraction
2020-05-27 AYTU Narrow Range Bar Range Contraction
2020-05-27 AYTU NR7 Range Contraction
2020-05-27 AYTU Bollinger Band Squeeze Range Contraction
2020-05-27 AYTU MACD Bearish Centerline Cross Bearish
2020-05-27 BLCM 180 Bullish Setup Bullish Swing Setup
2020-05-27 BLCM Slingshot Bullish Bullish Swing Setup
2020-05-27 EDAP Upper Bollinger Band Walk Strength
2020-05-27 EPIX NR7 Range Contraction
2020-05-27 EPIX Narrow Range Bar Range Contraction
2020-05-27 EPIX Upper Bollinger Band Walk Strength
2020-05-27 HARP Slingshot Bullish Bullish Swing Setup
2020-05-27 HARP Parabolic Rise Strength
2020-05-27 HARP Upper Bollinger Band Walk Strength
2020-05-27 HARP Volume Surge Other
2020-05-27 INO 20 DMA Support Bullish
2020-05-27 INO MACD Bearish Signal Line Cross Bearish
2020-05-27 IONS 20 DMA Support Bullish
2020-05-27 ISR Narrow Range Bar Range Contraction
2020-05-27 ISR Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 ISR NR7 Range Contraction
2020-05-27 JAZZ Crossed Above 20 DMA Bullish
2020-05-27 JAZZ 180 Bullish Setup Bullish Swing Setup
2020-05-27 MYGN 50 DMA Support Bullish
2020-05-27 MYGN Pocket Pivot Bullish Swing Setup
2020-05-27 MYOV Bollinger Band Squeeze Range Contraction
2020-05-27 MYOV Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 MYOV 180 Bullish Setup Bullish Swing Setup
2020-05-27 MYOV 20 DMA Support Bullish
2020-05-27 MYOV Hammer Candlestick Bullish
2020-05-27 MYOV Doji - Bullish? Reversal
2020-05-27 MYOV 1,2,3 Pullback Bullish Bullish Swing Setup
2020-05-27 OPK Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 OPK New Downtrend Bearish
2020-05-27 OPK Hammer Candlestick Bullish
2020-05-27 PDSB Calm After Storm Range Contraction
2020-05-27 PDSB Upper Bollinger Band Walk Strength
2020-05-27 PGNX Stochastic Reached Overbought Strength
2020-05-27 PGNX 20 DMA Support Bullish
2020-05-27 PROF Bollinger Band Squeeze Range Contraction
2020-05-27 SLRX 1,2,3 Pullback Bullish Bullish Swing Setup
2020-05-27 SLRX Calm After Storm Range Contraction
2020-05-27 SLRX Upper Bollinger Band Walk Strength
2020-05-27 SLRX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 SNY Cup with Handle Other
2020-05-27 SPPI Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-05-27 SPPI Hammer Candlestick Bullish
2020-05-27 SPPI 20 DMA Resistance Bearish
2020-05-27 VERU 20 DMA Resistance Bearish

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, some grow relatively quickly. The cancer cells may spread from the prostate to other areas of the body, particularly the bones and lymph nodes. It may initially cause no symptoms. In later stages, it can lead to difficulty urinating, blood in the urine or pain in the pelvis, back, or when urinating. A disease known as benign prostatic hyperplasia may produce similar symptoms. Other late symptoms may include feeling tired due to low levels of red blood cells.Factors that increase the risk of prostate cancer include older age, a family history of the disease, and race. About 99% of cases occur in males over the age of 50. Having a first-degree relative with the disease increases the risk two to threefold. In the United States, it is more common in the African American population than the White American population. Other factors that may be involved include a diet high in processed meat, red meat or milk products or low in certain vegetables. An association with gonorrhea has been found, but a reason for this relationship has not been identified. An increased risk is associated with the BRCA mutations. Prostate cancer is diagnosed by biopsy. Medical imaging may then be done to determine if the cancer has spread to other parts of the body.Prostate cancer screening is controversial. Prostate-specific antigen (PSA) testing increases cancer detection, but it is controversial regarding whether it improves outcomes. Informed decision making is recommended when it comes to screening among those 55 to 69 years old. Testing, if carried out, is more reasonable in those with a longer life expectancy. While 5α-reductase inhibitors appear to decrease low-grade cancer risk, they do not affect high-grade cancer risk and thus are not recommended for prevention. Supplementation with vitamins or minerals does not appear to affect the risk.Many cases are managed with active surveillance or watchful waiting. Other treatments may include a combination of surgery, radiation therapy, hormone therapy or chemotherapy. When it only occurs inside the prostate, it may be curable. In those in whom the disease has spread to the bones, pain medications, bisphosphonates and targeted therapy, among others, may be useful. Outcomes depend on a person's age and other health problems as well as how aggressive and extensive the cancer is. Most men with prostate cancer do not end up dying from the disease. The 5-year survival rate in the United States is 99%. Globally, it is the second most common type of cancer and the fifth leading cause of cancer-related death in men. In 2012, it occurred in 1.1 million men and caused 307,000 deaths. It was the most common cancer in males in 84 countries, occurring more commonly in the developed world. Rates have been increasing in the developing world. Detection increased significantly in the 1980s and 1990s in many areas due to increased PSA testing. Studies of males who died from unrelated causes have found prostate cancer in 30% to 70% of those over age 60.

More about Prostate Cancer